Compare Canadian Natural Resources Ltd. (CNQ) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canadian Natural Resources Ltd. vs Cronos Group Inc — how do they compare? Canadian Natural Resources Ltd. trades at $47.72 (market cap $98.11B), while Cronos Group Inc trades at $3.08 (market cap $1.14B). The key difference: Canadian Natural Resources Ltd. is far larger — about 86.1× Cronos Group Inc's market cap, and Canadian Natural Resources Ltd. pays a 3.73% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CNQ | CRON | |
|---|---|---|
Market Cap | $98.11B | $1.14B |
Sector | Energy | Health |
52-Week High | $50.55 | $3.27 |
52-Week Low | $29.31 | $2.30 |
Enterprise Value | $108.54B | $341.13M |
Dividend Yield | 3.73% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Canadian Natural Resources Ltd.
Canadian Natural Resources is one of the largest oil and natural gas producers in western Canada, supplemented by operations in the North Sea and Offshore Africa. The company's portfolio includes light and medium oil, heavy oil, bitumen, synthetic oil, natural gas liquids, and natural gas. Production averaged 1.16 million barrels of oil equivalent per day in 2020, and the company estimates that it holds over 11.5 billion boe of proven and probable crude oil and natural gas reserves.
Read more on CNQ →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
